Multiply Labs’ biomanufacturing robot to “slash cell therapy costs”
The technology is designed to improve patient accessibility to cell therapies by improving manufacturing efficiency.
Cytiva Navigating cell therapy WP 4
Cell and gene therapies on correction course but not sinking
Gilead’s Kite scoops in vivo CAR-T specialist Interius for $350m
Sartorius to invest $3m for minority share in biotech start-up Nanotein
ViroCell and AvenCell to advance allogeneic CAR-T therapy manufacture
UK enacts law to decentralise manufacture of personalised treatments
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
DoH and Children’s National Hospital link for cell and gene therapy
